Plain-English translation of NCT04917705 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying people with systemic sclerosis (a hardening of the skin and connective tissue) or inflammatory myopathies (muscle inflammation diseases) to discover biological fingerprints in the blood, skin, and muscle tissue. By examining these samples at the cellular and molecular level, the study aims to find markers that could help doctors diagnose these diseases earlier and predict how they will progress in individual patients.
These rare diseases are often hard to diagnose, and doctors currently have limited ways to predict which patients will have mild versus severe disease. This research seeks to discover biological signatures that could lead to better, faster diagnosis and help personalize treatment decisions in the future.
You likely qualify if…
You likely don't qualify if…
You will have an initial visit where baseline blood and tissue samples (including a small skin biopsy and possibly a muscle biopsy) are collected. Over the next 5 years, you will continue your regular medical care with 1–2 visits per year, and the study team will collect two additional sets of samples during that time. Your regular treatment and medical follow-up will not change; the extra samples are taken alongside routine care to support the research.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France